Fred Alger Management’s Arcturus Therapeutics ARCT Stock Holding History

Fred Alger Management’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,529	Closed	-$237K	–	497
2016 Q2	$237K	Sell	7,529 -1,428	-16%	-$45K	﹤0.01%	408
2016 Q1	$238K	Sell	8,957 -16,143	-64%	-$547K	﹤0.01%	442
2015 Q4	$1.1M	Buy	25,100 +1,536	+7%	+$69.2K	0.01%	377
2015 Q3	$996K	Buy	23,564 +6,964	+42%	+$366K	0.01%	389
2015 Q2	$760K	Buy	+16,600	New	+$761K	﹤0.01%	441

Other funds holding ARCT

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Fred Alger Management's ARCT Position: Q3 2016 in Review

Fred Alger Management sold out of Arcturus Therapeutics (ARCT) in Q3 2016, closing a stake of 7,529 shares — an estimated $237K sold.

Fred Alger Management first reported a position in ARCT in Q2 2015 and held it in 5 quarters. The position peaked at $1.1M in Q4 2015. 43 funds tracked by Wall St. Rank hold ARCT as of Q3 2016.

Fred Alger Management reported no remaining Arcturus Therapeutics position as of Q3 2016 after selling out during the quarter.
Fred Alger Management sold 7,529 Arcturus Therapeutics shares in Q3 2016, an estimated $237K.
Fred Alger Management first reported a position in Arcturus Therapeutics in Q2 2015 and held it in 5 quarters.
Fred Alger Management's Arcturus Therapeutics position peaked at $1.1M in Q4 2015.
43 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2016.

Based on Fred Alger Management's 13F filing for Q3 2016, filed 14 Nov 2016.